{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:36Z","timestamp":1791928716887,"version":"4.3.4"},"reference-count":70,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"DOI":"10.1167\/iovs.18-25761","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T11:30:49Z","timestamp":1551439849000},"page":"868","source":"Crossref","is-referenced-by-count":19,"title":["Mediators of Corneal Haze Following Implantation of Presbyopic Corneal Inlays"],"prefix":"10.1167","volume":"60","author":[{"given":"Beau J.","family":"Fenner","sequence":"first","affiliation":[{"name":"Singapore National Eye Centre, Singapore"},{"name":"Singapore Eye Research Institute, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chi","family":"Liu","sequence":"additional","affiliation":[{"name":"Singapore National Eye Centre, Singapore"},{"name":"Singapore Eye Research Institute, Singapore"},{"name":"Eye Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Kwan","family":"Koh","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Statistics and Applied Probability, National University of Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger W.","family":"Beuerman","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore"},{"name":"Eye Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore"},{"name":"Neuroscience Signature Research Program, Duke-NUS Graduate Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore"},{"name":"Eye Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore"},{"name":"Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian T. S.","family":"Theng","sequence":"additional","affiliation":[{"name":"Eagle Eye Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodhbir S.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Singapore National Eye Centre, Singapore"},{"name":"Singapore Eye Research Institute, Singapore"},{"name":"Eye Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"key":"i1552-5783-60-4-868-b01","doi-asserted-by":"crossref","unstructured":"Moarefi MA, Bafna S, Wiley W. A review of presbyopia treatment with corneal inlays. Ophthalmol Ther. 2017; 6: 55\u201365.","DOI":"10.1007\/s40123-017-0085-7"},{"key":"i1552-5783-60-4-868-b02","doi-asserted-by":"crossref","unstructured":"Konstantopoulos A, Mehta JS. Surgical compensation of presbyopia with corneal inlays. Expert Rev Med Devices. 2015; 12: 341\u2013352.","DOI":"10.1586\/17434440.2015.1007124"},{"key":"i1552-5783-60-4-868-b03","doi-asserted-by":"crossref","unstructured":"Lindstrom RL, Macrae SM, Pepose JS, Hoopes PC Sr. Corneal inlays for presbyopia correction. Curr Opin Ophthalmol. 2013; 24: 281\u2013287.","DOI":"10.1097\/ICU.0b013e328362293e"},{"key":"i1552-5783-60-4-868-b04","doi-asserted-by":"crossref","unstructured":"Vukich JA, Durrie DS, Pepose JS, Thompson V, van de Pol C, Lin L. Evaluation of the small-aperture intracorneal inlay: three-year results from the cohort of the U.S. Food and Drug Administration clinical trial. J Cataract Refract Surg. 2018; 44: 541\u2013556.","DOI":"10.1016\/j.jcrs.2018.02.023"},{"key":"i1552-5783-60-4-868-b05","unstructured":"Moshirfar M, Desautels JD, Wallace RT, Koen N, Hoopes PC. Comparison of FDA safety and efficacy data for KAMRA and Raindrop corneal inlays. Int J Ophthalmol. 2017; 10: 1446\u20131451."},{"key":"i1552-5783-60-4-868-b06","doi-asserted-by":"crossref","unstructured":"Binder PS. Intracorneal inlays for the correction of presbyopia. Eye Contact Lens. 2017; 43: 267\u2013275.","DOI":"10.1097\/ICL.0000000000000381"},{"key":"i1552-5783-60-4-868-b07","doi-asserted-by":"crossref","unstructured":"Beer SMC, Santos R, Nakano EM, et al. One-year clinical outcomes of a corneal inlay for presbyopia. Cornea. 2017; 36: 816\u2013820.","DOI":"10.1097\/ICO.0000000000001195"},{"key":"i1552-5783-60-4-868-b08","doi-asserted-by":"crossref","unstructured":"Whitman J, Dougherty PJ, Parkhurst GD, et al. Treatment of presbyopia in emmetropes using a shape-changing corneal inlay: one-year clinical outcomes. Ophthalmology. 2016; 123: 466\u2013475.","DOI":"10.1016\/j.ophtha.2015.11.011"},{"key":"i1552-5783-60-4-868-b09","doi-asserted-by":"crossref","unstructured":"Ong HS, Chan AS, Yau CW, Mehta JS. Corneal inlays for presbyopia explanted due to corneal haze. J Refract Surg. 2018; 34: 357\u2013360.","DOI":"10.3928\/1081597X-20180308-01"},{"key":"i1552-5783-60-4-868-b10","doi-asserted-by":"crossref","unstructured":"Fahd D, de la Cruz J, Jain S, Azar DT. Corneal haze after refractive surgery. In: Alio JL, Azar DT, eds. Management of Complications in Refractive Surgery. Cham, Switzerland: Springer Nature; 2018: 259\u2013267.","DOI":"10.1007\/978-3-319-60561-6_29"},{"key":"i1552-5783-60-4-868-b11","doi-asserted-by":"crossref","unstructured":"Antonios R, Jabbur NS, Ahmed MA, Awwad ST. Refractory interface haze developing after epithelial ingrowth following laser in situ keratomileusis and small aperture corneal inlay implantation. Am J Ophthalmol Case Rep. 2018; 10: 10\u201312.","DOI":"10.1016\/j.ajoc.2018.01.034"},{"key":"i1552-5783-60-4-868-b12","doi-asserted-by":"crossref","unstructured":"Mulet ME, Alio JL, Knorz MC. Hydrogel intracorneal inlays for the correction of hyperopia: outcomes and complications after 5 years of follow-up. Ophthalmology. 2009; 116: 1455\u20131460.","DOI":"10.1016\/j.ophtha.2009.05.019"},{"key":"i1552-5783-60-4-868-b13","doi-asserted-by":"crossref","unstructured":"Tong L, Zhou L, Beuerman RW, Zhao SZ, Li XR. Association of tear proteins with Meibomian gland disease and dry eye symptoms. Br J Ophthalmol. 2011; 95: 848\u2013852.","DOI":"10.1136\/bjo.2010.185256"},{"key":"i1552-5783-60-4-868-b14","doi-asserted-by":"crossref","unstructured":"Zhou L, Beuerman RW, Chan CM, et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res. 2009; 8: 4889\u20134905.","DOI":"10.1021\/pr900686s"},{"key":"i1552-5783-60-4-868-b15","doi-asserted-by":"crossref","unstructured":"Matheis N, Okrojek R, Grus FH, Kahaly GJ. Proteomics of tear fluid in thyroid-associated orbitopathy. Thyroid. 2012; 22: 1039\u20131045.","DOI":"10.1089\/thy.2012.0119"},{"key":"i1552-5783-60-4-868-b16","doi-asserted-by":"crossref","unstructured":"Zhou L, Wei R, Zhao P, Koh SK, Beuerman RW, Ding C. Proteomic analysis revealed the altered tear protein profile in a rabbit model of Sjogren's syndrome-associated dry eye. Proteomics. 2013; 13: 2469\u20132481.","DOI":"10.1002\/pmic.201200230"},{"key":"i1552-5783-60-4-868-b17","doi-asserted-by":"crossref","unstructured":"Leonardi A, Palmigiano A, Mazzola EA, et al. Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics. Allergy. 2014; 69: 254\u2013260.","DOI":"10.1111\/all.12331"},{"key":"i1552-5783-60-4-868-b18","doi-asserted-by":"crossref","unstructured":"D'Souza S, Petznick A, Tong L, et al. Comparative analysis of two femtosecond LASIK platforms using iTRAQ quantitative proteomics. Invest Ophthalmol Vis Sci. 2014; 55: 3396\u20133402.","DOI":"10.1167\/iovs.14-14113"},{"key":"i1552-5783-60-4-868-b19","doi-asserted-by":"crossref","unstructured":"Lim RR, Tan A, Liu YC, et al. ITF2357 transactivates Id3 and regulate TGFbeta\/BMP7 signaling pathways to attenuate corneal fibrosis. Sci Rep. 2016; 6: 20841.","DOI":"10.1038\/srep20841"},{"key":"i1552-5783-60-4-868-b20","doi-asserted-by":"crossref","unstructured":"Majmudar PA, Schallhorn SC, Cason JB, et al. Mitomycin-C in corneal surface excimer laser ablation techniques: a report by the American Academy of Ophthalmology. Ophthalmology. 2015; 122: 1085\u20131095.","DOI":"10.1016\/j.ophtha.2015.01.019"},{"key":"i1552-5783-60-4-868-b21","doi-asserted-by":"crossref","unstructured":"Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000; 11: 478\u2013483.","DOI":"10.1097\/00055735-200012000-00016"},{"key":"i1552-5783-60-4-868-b22","doi-asserted-by":"crossref","unstructured":"Dos Santos PF, Mansur DS. Beyond ISGlylation: functions of free intracellular and extracellular ISG15. J Interferon Cytokine Res. 2017; 37: 246\u2013253.","DOI":"10.1089\/jir.2016.0103"},{"key":"i1552-5783-60-4-868-b23","doi-asserted-by":"crossref","unstructured":"Ritchie KJ, Zhang DE. ISG15: the immunological kin of ubiquitin. Semin Cell Dev Biol. 2004; 15: 237\u2013246.","DOI":"10.1016\/j.semcdb.2003.12.005"},{"key":"i1552-5783-60-4-868-b24","doi-asserted-by":"crossref","unstructured":"Taylor JL, D'Cunha J, Tom P, O'Brien WJ, Borden EC. Production of ISG-15, an interferon-inducible protein, in human corneal cells. J Interferon Cytokine Res. 1996; 16: 937\u2013940.","DOI":"10.1089\/jir.1996.16.937"},{"key":"i1552-5783-60-4-868-b25","doi-asserted-by":"crossref","unstructured":"Dong C, Gao N, Ross BX, Yu FX. ISG15 in host defense against Candida albicans infection in a mouse model of fungal keratitis. Invest Ophthalmol Vis Sci. 2017; 58: 2948\u20132958.","DOI":"10.1167\/iovs.17-21476"},{"key":"i1552-5783-60-4-868-b26","doi-asserted-by":"crossref","unstructured":"Wegener KL, Partridge AW, Han J, et al. Structural basis of integrin activation by talin. Cell. 2007; 128: 171\u2013182.","DOI":"10.1016\/j.cell.2006.10.048"},{"key":"i1552-5783-60-4-868-b27","doi-asserted-by":"crossref","unstructured":"Stadtmann A, Zarbock A. The role of kindlin in neutrophil recruitment to inflammatory sites. Curr Opin Hematol. 2017; 24: 38\u201345.","DOI":"10.1097\/MOH.0000000000000294"},{"key":"i1552-5783-60-4-868-b28","doi-asserted-by":"crossref","unstructured":"Ishizaki M, Wakamatsu K, Matsunami T, et al. Dynamics of the expression of cytoskeleton components and adherens molecules by fibroblastic cells in alkali-burned and lacerated corneas. Exp Eye Res. 1994; 59: 537\u2013549.","DOI":"10.1006\/exer.1994.1139"},{"key":"i1552-5783-60-4-868-b29","doi-asserted-by":"crossref","unstructured":"Moon KE, Gorski JP, Hugli TE. Complete primary structure of human C4a anaphylatoxin. J Biol Chem. 1981; 256: 8685\u20138692.","DOI":"10.1016\/S0021-9258(19)68898-8"},{"key":"i1552-5783-60-4-868-b30","doi-asserted-by":"crossref","unstructured":"Gorski JP, Hugli TE, Muller-Eberhard HJ. C4a: the third anaphylatoxin of the human complement system. Proc Natl Acad Sci U S A. 1979; 76: 5299\u20135302.","DOI":"10.1073\/pnas.76.10.5299"},{"key":"i1552-5783-60-4-868-b31","doi-asserted-by":"crossref","unstructured":"Gardner BP, Pleyer U, Mondino BJ, Sumner HL, Frieberg ML, Imperia PS. Complement-derived anaphylatoxins in human donor corneas treated with excimer laser. Ophthalmic Surg Lasers. 1995; 26: 568\u2013571.","DOI":"10.3928\/1542-8877-19951101-12"},{"key":"i1552-5783-60-4-868-b32","doi-asserted-by":"crossref","unstructured":"Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol. 2004; 41: 355\u2013367.","DOI":"10.1016\/j.molimm.2004.02.005"},{"key":"i1552-5783-60-4-868-b33","doi-asserted-by":"crossref","unstructured":"Griffiths MR, Neal JW, Fontaine M, Das T, Gasque P. Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. J Immunol. 2009; 182: 4368\u20134377.","DOI":"10.4049\/jimmunol.0800205"},{"key":"i1552-5783-60-4-868-b34","doi-asserted-by":"crossref","unstructured":"Kim TH, Lee YH, Kim KH, et al. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. Am J Respir Crit Care Med. 2010; 182: 633\u2013642.","DOI":"10.1164\/rccm.200905-0659OC"},{"key":"i1552-5783-60-4-868-b35","doi-asserted-by":"crossref","unstructured":"Gangadharan B, Antrobus R, Dwek RA, Zitzmann N. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin Chem. 2007; 53: 1792\u20131799.","DOI":"10.1373\/clinchem.2007.089144"},{"key":"i1552-5783-60-4-868-b36","doi-asserted-by":"crossref","unstructured":"Srinivasan S, Thangavelu M, Zhang L, Green KB, Nichols KK. iTRAQ quantitative proteomics in the analysis of tears in dry eye patients. Invest Ophthalmol Vis Sci. 2012; 53: 5052\u20135059.","DOI":"10.1167\/iovs.11-9022"},{"key":"i1552-5783-60-4-868-b37","doi-asserted-by":"crossref","unstructured":"Sen DK, Sarin GS. Immunoglobulin concentrations in human tears in ocular diseases. Br J Ophthalmol. 1979; 63: 297\u2013300.","DOI":"10.1136\/bjo.63.5.297"},{"key":"i1552-5783-60-4-868-b38","doi-asserted-by":"crossref","unstructured":"Garrett SC, Varney KM, Weber DJ, Bresnick AR. S100A4, a mediator of metastasis. J Biol Chem. 2006; 281: 677\u2013680.","DOI":"10.1074\/jbc.R500017200"},{"key":"i1552-5783-60-4-868-b39","doi-asserted-by":"crossref","unstructured":"Fei F, Qu J, Li C, Wang X, Li Y, Zhang S. Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies. Cell Biosci. 2017; 7: 64.","DOI":"10.1186\/s13578-017-0191-1"},{"key":"i1552-5783-60-4-868-b40","doi-asserted-by":"crossref","unstructured":"Schneider M, Hansen JL, Sheikh SP. S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? J Mol Med (Berl). 2008; 86: 507\u2013522.","DOI":"10.1007\/s00109-007-0301-3"},{"key":"i1552-5783-60-4-868-b41","doi-asserted-by":"crossref","unstructured":"Samolov B, Steen B, Seregard S, van der Ploeg I, Montan P, Kvanta A. Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice. Exp Eye Res. 2005; 80: 159\u2013166.","DOI":"10.1016\/j.exer.2004.08.023"},{"key":"i1552-5783-60-4-868-b42","doi-asserted-by":"crossref","unstructured":"Ryan DG, Taliana L, Sun L, Wei ZG, Masur SK, Lavker RM. Involvement of S100A4 in stromal fibroblasts of the regenerating cornea. Invest Ophthalmol Vis Sci. 2003; 44: 4255\u20134262.","DOI":"10.1167\/iovs.03-0578"},{"key":"i1552-5783-60-4-868-b43","unstructured":"Nubile M, Lanzini M, Calienno R, et al. S100 A and B expression in normal and inflamed human limbus. Mol Vis. 2013; 19: 146\u2013152."},{"key":"i1552-5783-60-4-868-b44","doi-asserted-by":"crossref","unstructured":"Kenney MC, Chwa M, Alba A, Saghizadeh M, Huang ZS, Brown DJ. Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr Eye Res. 1998; 17: 238\u2013246.","DOI":"10.1076\/ceyr.17.3.238.5222"},{"key":"i1552-5783-60-4-868-b45","doi-asserted-by":"crossref","unstructured":"Kernacki KA, Chunta JL, Barrett RP, Hazlett LD. TIMP-1 role in protection against Pseudomonas aeruginosa-induced corneal destruction. Exp Eye Res. 2004; 78: 1155\u20131162.","DOI":"10.1016\/j.exer.2003.12.005"},{"key":"i1552-5783-60-4-868-b46","doi-asserted-by":"crossref","unstructured":"Nawaz MS, Giarda E, Bedogni F, et al. CDKL5 and Shootin1 interact and concur in regulating neuronal polarization. PLoS One. 2016; 11: e0148634.","DOI":"10.1371\/journal.pone.0148634"},{"key":"i1552-5783-60-4-868-b47","doi-asserted-by":"crossref","unstructured":"Higashiguchi Y, Katsuta K, Minegishi T, Yonemura S, Urasaki A, Inagaki N. Identification of a shootin1 isoform expressed in peripheral tissues. Cell Tissue Res. 2016; 366: 75\u201387.","DOI":"10.1007\/s00441-016-2415-9"},{"key":"i1552-5783-60-4-868-b48","doi-asserted-by":"crossref","unstructured":"Wang Q, Wang X, Le Y, et al. Rnaset2 inhibits melanocyte outgrowth possibly through interacting with shootin1. J Dermatol Sci. 2015; 80: 25\u201332.","DOI":"10.1016\/j.jdermsci.2015.07.004"},{"key":"i1552-5783-60-4-868-b49","doi-asserted-by":"crossref","unstructured":"Toriyama M, Kozawa S, Sakumura Y, Inagaki N. Conversion of a signal into forces for axon outgrowth through Pak1-mediated shootin1 phosphorylation. Curr Biol. 2013; 23: 529\u2013534.","DOI":"10.1016\/j.cub.2013.02.017"},{"key":"i1552-5783-60-4-868-b50","doi-asserted-by":"crossref","unstructured":"Toriyama M, Shimada T, Kim KB, et al. Shootin1: a protein involved in the organization of an asymmetric signal for neuronal polarization. J Cell Biol. 2006; 175: 147\u2013157.","DOI":"10.1083\/jcb.200604160"},{"key":"i1552-5783-60-4-868-b51","doi-asserted-by":"crossref","unstructured":"Winiarczyk M, Kaarniranta K, Winiarczyk S, Adaszek L, Winiarczyk D, Mackiewicz J. Tear film proteome in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2018; 256: 1127\u20131139.","DOI":"10.1007\/s00417-018-3984-y"},{"key":"i1552-5783-60-4-868-b52","doi-asserted-by":"crossref","unstructured":"Vanhoof G, De Meester I, Goossens F, Hendriks D, Scharpe S, Yaron A. Kininase activity in human platelets: cleavage of the Arg1-Pro2 bond of bradykinin by aminopeptidase P. Biochem Pharmacol. 1992; 44: 479\u2013487.","DOI":"10.1016\/0006-2952(92)90439-P"},{"key":"i1552-5783-60-4-868-b53","doi-asserted-by":"crossref","unstructured":"Rusu I, Yaron A. Aminopeptidase P from human leukocytes. Eur J Biochem. 1992; 210: 93\u2013100.","DOI":"10.1111\/j.1432-1033.1992.tb17395.x"},{"key":"i1552-5783-60-4-868-b54","doi-asserted-by":"crossref","unstructured":"Yoon SH, Bae YS, Mun MS, et al. Developmental retardation, microcephaly, and peptiduria in mice without aminopeptidase P1. Biochem Biophys Res Commun. 2012; 429: 204\u2013209.","DOI":"10.1016\/j.bbrc.2012.10.104"},{"key":"i1552-5783-60-4-868-b55","doi-asserted-by":"crossref","unstructured":"Chromy BA, Eldridge A, Forsberg JA, et al. Wound outcome in combat injuries is associated with a unique set of protein biomarkers. J Transl Med. 2013; 11: 281.","DOI":"10.1186\/1479-5876-11-281"},{"key":"i1552-5783-60-4-868-b56","unstructured":"Wright QG. Role of Microbiota in Strengthening Ocular Mucosal Barrier Function Through Secretory IgA [master's thesis]. Harvard Extension School, Cambridge, MA: Harvard University; 2017: 41."},{"key":"i1552-5783-60-4-868-b57","doi-asserted-by":"crossref","unstructured":"Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015; 49: 17\u201345.","DOI":"10.1016\/j.preteyeres.2015.07.002"},{"key":"i1552-5783-60-4-868-b58","doi-asserted-by":"crossref","unstructured":"Pisella PJ, Auzerie O, Bokobza Y, Debbasch C, Baudouin C. Evaluation of corneal stromal changes in vivo after laser in situ keratomileusis with confocal microscopy. Ophthalmology. 2001; 108: 1744\u20131750.","DOI":"10.1016\/S0161-6420(01)00771-0"},{"key":"i1552-5783-60-4-868-b59","doi-asserted-by":"crossref","unstructured":"Spirn MJ, Dawson DG, Rubinfeld RS, et al. Histopathological analysis of post-laser-assisted in situ keratomileusis corneal ectasia with intrastromal corneal ring segments. Arch Ophthalmol. 2005; 123: 1604\u20131607.","DOI":"10.1001\/archopht.123.11.1604"},{"key":"i1552-5783-60-4-868-b60","doi-asserted-by":"crossref","unstructured":"Chen L, Deng H, Cui H, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018; 9: 7204\u20137218.","DOI":"10.18632\/oncotarget.23208"},{"key":"i1552-5783-60-4-868-b61","doi-asserted-by":"crossref","unstructured":"Saha S, Harrison SH, Chen JY. Dissecting the human plasma proteome and inflammatory response biomarkers. Proteomics. 2009; 9: 470\u2013484.","DOI":"10.1002\/pmic.200800507"},{"key":"i1552-5783-60-4-868-b62","unstructured":"Brennan K. Risk Management for Corneal Inlays. Rev Ophthalmol. 2017. Available at: https:\/\/www.reviewofophthalmology.com\/article\/risk-management-for-corneal-inlays. Accessed February 16, 2019."},{"key":"i1552-5783-60-4-868-b63","doi-asserted-by":"crossref","unstructured":"Azkargorta M, Soria J, Acera A, Iloro I, Elortza F. Human tear proteomics and peptidomics in ophthalmology: toward the translation of proteomic biomarkers into clinical practice. J Proteomics. 2017; 150: 359\u2013367.","DOI":"10.1016\/j.jprot.2016.05.006"},{"key":"i1552-5783-60-4-868-b64","doi-asserted-by":"crossref","unstructured":"Wu K, Zhang Y. Clinical application of tear proteomics: present and future prospects. Proteomics Clin Appl. 2007; 1: 972\u2013982.","DOI":"10.1002\/prca.200700125"},{"key":"i1552-5783-60-4-868-b65","doi-asserted-by":"crossref","unstructured":"Zhou L, Beuerman RW. Tear analysis in ocular surface diseases. Prog Retin Eye Res. 2012; 31: 527\u2013550.","DOI":"10.1016\/j.preteyeres.2012.06.002"},{"key":"i1552-5783-60-4-868-b66","doi-asserted-by":"crossref","unstructured":"Semba RD, Enghild JJ, Venkatraman V, Dyrlund TF, Van Eyk JE. The Human Eye Proteome Project: perspectives on an emerging proteome. Proteomics. 2013; 13: 2500\u20132511.","DOI":"10.1002\/pmic.201300075"},{"key":"i1552-5783-60-4-868-b67","doi-asserted-by":"crossref","unstructured":"Clamp M, Fry B, Kamal M, et al. Distinguishing protein-coding and noncoding genes in the human genome. Proc Natl Acad Sci U S A. 2007; 104: 19428\u201319433.","DOI":"10.1073\/pnas.0709013104"},{"key":"i1552-5783-60-4-868-b68","doi-asserted-by":"crossref","unstructured":"Roy PJ, Stuart JM, Lund J, Kim SK. Chromosomal clustering of muscle-expressed genes in Caenorhabditis elegans. Nature. 2002; 418: 975\u2013979.","DOI":"10.1038\/nature01012"},{"key":"i1552-5783-60-4-868-b69","unstructured":"Administration USFD. Increased Risk of Corneal Haze Associated With the Raindrop Near Vision Inlay: FDA Safety Communication. 2018. Available at: https:\/\/www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/ucm623973.htm. February 16, 2019."},{"key":"i1552-5783-60-4-868-b70","doi-asserted-by":"crossref","unstructured":"The Gene Ontology C. Expansion of the Gene Ontology knowledgebase and resources. Nucleic Acids Res. 2017; 45: D331\u2013D338.","DOI":"10.1093\/nar\/gkw1108"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2727193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:12Z","timestamp":1791927072000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-25761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-25761","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}